Showing 1 to 7 of 7 results
Innovative HIV Cure Approaches Show Promise in Trials
Building on the success of stem cell transplants, innovative HIV cure approaches like combination therapies (including mRNA delivery and novel antibodies) and gene therapies are showing promise in trials, particularly in children and early-diagnosed adults, offering hope for a widely accessible cure...
Innovative HIV Cure Approaches Show Promise in Trials
Building on the success of stem cell transplants, innovative HIV cure approaches like combination therapies (including mRNA delivery and novel antibodies) and gene therapies are showing promise in trials, particularly in children and early-diagnosed adults, offering hope for a widely accessible cure...
Progress
36% Bias Score
Novel Antivenom Developed from Hyper-Immune Man's Blood Shows Promise
Scientists created a highly effective antivenom using antibodies from a man who'd been bitten hundreds of times by venomous snakes; mouse trials showed effectiveness against multiple species, potentially revolutionizing snakebite treatment globally.
Novel Antivenom Developed from Hyper-Immune Man's Blood Shows Promise
Scientists created a highly effective antivenom using antibodies from a man who'd been bitten hundreds of times by venomous snakes; mouse trials showed effectiveness against multiple species, potentially revolutionizing snakebite treatment globally.
Progress
40% Bias Score
Snakebite Antivenom Breakthrough from Self-Experimentation
Tim Friede's self-experimentation with snake venom, spanning 18 years, has led to the discovery of two broadly neutralizing antibodies in his blood by Columbia University scientists, potentially revolutionizing antivenom treatment for snakebites affecting 110,000 people annually.
Snakebite Antivenom Breakthrough from Self-Experimentation
Tim Friede's self-experimentation with snake venom, spanning 18 years, has led to the discovery of two broadly neutralizing antibodies in his blood by Columbia University scientists, potentially revolutionizing antivenom treatment for snakebites affecting 110,000 people annually.
Progress
36% Bias Score
Novel Antivenom Shows Promise Against Multiple Elapid Snake Venoms
A new antivenom, created using antibodies from a human who repeatedly exposed himself to snake venom, shows complete protection against 13 elapid snake species in mice and partial protection against 6 others; further testing in dogs is planned.
Novel Antivenom Shows Promise Against Multiple Elapid Snake Venoms
A new antivenom, created using antibodies from a human who repeatedly exposed himself to snake venom, shows complete protection against 13 elapid snake species in mice and partial protection against 6 others; further testing in dogs is planned.
Progress
32% Bias Score
China to Develop Child-Specific COVID-19 Antibodies
Dr. Zhong Nanshan announced his team is developing COVID-19 antibodies for children under 5 due to insufficient research and safety data on current treatments; COVID-19 positivity rates have increased from 7.5 percent to 16.2 percent in outpatient cases between March 31 and May 4, underscoring the u...
China to Develop Child-Specific COVID-19 Antibodies
Dr. Zhong Nanshan announced his team is developing COVID-19 antibodies for children under 5 due to insufficient research and safety data on current treatments; COVID-19 positivity rates have increased from 7.5 percent to 16.2 percent in outpatient cases between March 31 and May 4, underscoring the u...
Progress
44% Bias Score
Novel Antivenom Shows Broad Protection Against Elapid Snakebites
A novel antivenom, derived from the blood of a man who self-injected snake venom for 18 years, shows unprecedented protection against multiple elapid snake species in animal tests, potentially revolutionizing snakebite treatment and saving the lives of up to 140,000 people annually.
Novel Antivenom Shows Broad Protection Against Elapid Snakebites
A novel antivenom, derived from the blood of a man who self-injected snake venom for 18 years, shows unprecedented protection against multiple elapid snake species in animal tests, potentially revolutionizing snakebite treatment and saving the lives of up to 140,000 people annually.
Progress
40% Bias Score
Novel Antivenom Developed Using Antibodies from Man Who Self-Administered Snake Venom
Tim Friede's 18-year self-experimentation involving over 850 snake venom doses resulted in a novel, broadly protective antivenom created by scientists using his antibodies; this antivenom offers protection against 13 of 19 deadliest snake species and could revolutionize snakebite treatment globally.
Novel Antivenom Developed Using Antibodies from Man Who Self-Administered Snake Venom
Tim Friede's 18-year self-experimentation involving over 850 snake venom doses resulted in a novel, broadly protective antivenom created by scientists using his antibodies; this antivenom offers protection against 13 of 19 deadliest snake species and could revolutionize snakebite treatment globally.
Progress
40% Bias Score
Showing 1 to 7 of 7 results